NeuroPace Inc
NPCE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001528287
No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in NeuroPace Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- 0 vs. Q4 2022
- Shares held
- 17.7M
- +313.0K (+1.8%) vs. Q4 2022
- Total value
- $82.0M
- +$56.1M (+217.0%) vs. Q4 2022
- New holders
- 3
- 9 more added
- Sold out
- 3
- 3 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NPCE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 112 | $422.4M |
| Q1 2026 | 113 | $347.9M |
| Q4 2025 | 100 | $405.9M |
| Q3 2025 | 80 | $267.5M |
| Q2 2025 | 99 | $250.7M |
| Q1 2025 | 90 | $294.1M |
| Q4 2024 | 62 | $233.5M |
| Q3 2024 | 48 | $103.1M |
| Q2 2024 | 51 | $109.1M |
| Q1 2024 | 54 | $176.4M |
| Q4 2023 | 41 | $130.8M |
| Q3 2023 | 25 | $175.9M |
| Q2 2023 | 22 | $78.6M |
| Q1 2023 | 24 | $82.0M |
| Q4 2022 | 24 | $25.9M |
| Q3 2022 | 28 | $68.1M |
| Q2 2022 | 32 | $91.2M |
| Q1 2022 | 40 | $149.5M |
| Q4 2021 | 41 | $181.5M |
| Q3 2021 | 39 | $177.4M |
| Q2 2021 | 44 | $259.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding NeuroPace Inc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 118 | $548 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 219 | $1.02K | 0.00% | +151+222.1% | Added |
| BerganKDV Wealth Management, LLC | 420 | $1.95K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 784 | $4.00K | 0.00% | −4,928−86.3% | Reduced |
| UBS Group AG | 2,623 | $12.2K | 0.00% | +1,071+69.0% | Added |
| Financial Advocates Investment Management | 10,000 | $46.4K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 13,016 | $60.4K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 14,052 | $65.2K | 0.00% | +14,052 | New |
| Renaissance Technologies LLC | 14,500 | $67.0K | 0.00% | +1,100+8.2% | Added |
| Northern Trust Corp | 16,171 | $75.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 22,451 | $104.2K | 0.00% | 00.0% | Unchanged |
| SG Americas Securities, LLC | 25,388 | $118.0K | 0.00% | +25,388 | New |
| BlackRock Inc. | 32,471 | $150.7K | 0.00% | −2,076−6.0% | Reduced |
| Bridgeway Capital Management, LLC | 51,648 | $239.6K | 0.01% | +20,000+63.2% | Added |
| Geode Capital Management, LLC | 71,515 | $331.8K | 0.00% | 00.0% | Unchanged |
| Kent Lake Capital LLC | 127,676 | $592.4K | 0.40% | +127,676 | New |
| Vanguard Group Inc | 296,548 | $1.38M | 0.00% | +22,619+8.3% | Added |
| Nantahala Capital Management, LLC | 425,925 | $1.98M | 0.19% | −7,657−1.8% | Reduced |
| Millennium Management LLC | 731,610 | $3.40M | 0.00% | +39,711+5.7% | Added |
| FMR LLC | 1,492,931 | $6.93M | 0.00% | +43,005+3.0% | Added |
| Morgan Stanley | 2,258,016 | $10.5M | 0.00% | +69,423+3.2% | Added |
| Soleus Capital Management, L.P. | 2,428,714 | $11.3M | 1.40% | +59,711+2.5% | Added |
| OrbiMed Advisors LLC | 4,012,281 | $18.6M | 0.37% | 00.0% | Unchanged |
| KCK Ltd. | 5,621,111 | $26.1M | 38.74% | 00.0% | Unchanged |
| American Century Companies Inc | 0 | $0 | 0.00% | −72,508−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −23,692−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −58−100.0% | Sold out |